Cargando…
Loss of Regulator of G Protein Signaling 5 Exacerbates Obesity, Hepatic Steatosis, Inflammation and Insulin Resistance
BACKGROUND: The effect of regulator of G protein signaling 5 (RGS5) on cardiac hypertrophy, atherosclerosis and angiogenesis has been well demonstrated, but the role in the development of obesity and insulin resistance remains completely unknown. We determined the effect of RGS5 deficiency on obesit...
Autores principales: | Deng, Wei, Wang, Xinan, Xiao, Jinfeng, Chen, Kuoju, Zhou, Heng, Shen, Difei, Li, Hongliang, Tang, Qizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260252/ https://www.ncbi.nlm.nih.gov/pubmed/22272317 http://dx.doi.org/10.1371/journal.pone.0030256 |
Ejemplares similares
-
Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022) -
Loss of hnRNP A1 in murine skeletal muscle exacerbates high-fat diet-induced onset of insulin resistance and hepatic steatosis
por: Zhao, Mingxia, et al.
Publicado: (2019) -
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
por: Deveaux, Vanessa, et al.
Publicado: (2009) -
Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity
por: Zhu, Chonggui, et al.
Publicado: (2023) -
Loss of TDAG51 Results in Mature-Onset Obesity, Hepatic Steatosis, and Insulin Resistance by Regulating Lipogenesis
por: Basseri, Sana, et al.
Publicado: (2013)